Trials / Recruiting
RecruitingNCT05356039
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer
Survival, Quality of Life and Resectability in Locally Advanced Pancreatic Cancer - a Multicenter Prospective Observational Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Umeå University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to assess overall survival, quality of life and resection rates in locally advanced pancreatic cancer
Detailed description
This is a multicenter pragmatic prospective observational study including Nordic hospitals treating patients with borderline resectable and locally advanced pancreatic cancer. Eligibility will be assessed at regional multidisciplinary tumor boards. Patients with borderline resectable and locally advanced (non-endocrine) pancreatic cancer according to the National Comprehensive Cancer Network (NCCN) and the International Study Group of Pancreatic Surgery (ISGPS) are eligible for inclusion. The study is observational. Quality of life will be assessed in all study participants. The primary outcomes are exploration rates, resection rates and overall survival.
Conditions
- Pancreas Cancer
- Pancreas Neoplasm
- Pancreas Disease
- Pancreas Adenocarcinoma
- Surgery
- Chemotherapy Effect
- Quality of Life
- Locally Advanced Pancreatic Adenocarcinoma
- Borderline Resectable Pancreatic Adenocarcinoma
Timeline
- Start date
- 2022-04-19
- Primary completion
- 2025-05-01
- Completion
- 2028-05-01
- First posted
- 2022-05-02
- Last updated
- 2022-11-30
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT05356039. Inclusion in this directory is not an endorsement.